Metraipolis › archive › dc_e7ed955dff0a

Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy — Europe PMC PMID:42021467

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42021467
DOI
10.1002/iid3.70442
License (as archived)
solo-consultazione
Archived
2026-11-03T13:25:37.420Z
SHA-256 of the archived text
ffd149179af5a7caa1f766e68408f44547af5b2fe669f5908329886005b8641e
Stable URL of this page
https://metraipolis.com/documento/dc_e7ed955dff0a

How to cite

Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy — Europe PMC PMID:42021467 — Europe PMC (en), https://europepmc.org/article/MED/42021467 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7ed955dff0a (Metraipolis archive dc_e7ed955dff0a, sha256 ffd149179af5a7caa1f766e68408f44547af5b2fe669f5908329886005b8641e)
BibTeX
@misc{dce7ed955dff0a,
  title = {Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy — Europe PMC PMID:42021467},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42021467},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7ed955dff0a; sha256 ffd149179af5a7caa1f766e68408f44547af5b2fe669f5908329886005b8641e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42021467. Agents can read the archived copy with the MCP tool read_document.